new glp 1 coming to market GLP-1 Reach $180 Billion by 2035 at 8.7% CAGR GLP-1 Receptor Agonist Market Growth

I was struggling with my health and even simple activities like traveling were becoming harder

Though less popular than the newer weekly injections like semaglutide and tirzepatide , it still represented a meaningful cost line

Drinking or eating less, along with nausea, vomiting, or diarrhea, can all leave you more dehydrated and dry-mouthed

Its not about being hungry, its about being consistent

10-13 In subsequent trials where higher doses of the GLP-1/GIP agonists were used in non-diabetic obese subjects, weight loss of 15% to 21% of body weight was seen

Looking for Market Leaders Only two companies, Eli Lilly and Novo Nordisk, have sizable GLP-1s available today, and we expect them to dominate the market over the intermediate term